In seniors, hip fractures and resulting immobility result in high morbidity, and mortality of up to 30% in the first year. As yet, there is no therapy available to address the problem of impaired regeneration and mobility, and the consequences (including high mortality) after hip fracture surgery. Hipgen is a multicenter phase III trial which aims to bring allogenic placental cell therapy with... Read more
On May 4, 2019, the Asia Pacific Consortium on Osteoporosis (APCO) was launched at a meeting in Singapore. The meeting was attended by 24 clinical experts from across the Asia Pacific region. The consortium aims to develop solutions to pressing challenges facing osteoporosis management and fracture prevention in this highly populous part of the world. Read more
It is with great sadness that IOF learned of the sudden death of Professor Howard Morris, President of the International Federation of Clinical Chemistry (IFCC), who passed away on April 18, 2019, while in Kazakhstan where he was lecturing as an IFCC Visiting Lecturer. Read more
The Committee of National Societies (CNS) Day, held exclusively for IOF member societies, encompassed a full day’s programme of engaging and informative sessions that focused on topics of relevance to national patient societies worldwide. Following the successful event, IOF CEO’s stated: Read more
The Meeting, organized by the HIPGEN project’s coordinator Dr Tobias Winkler (Charité - Universitätsmedizin Berlin) in collaboration with host organization ALTA, brought together more than 30 participants representing a network of ten organizations located in eight countries. It was an important opportunity for all the key stakeholders to update each other on progress and discuss current... Read more
The Committee of National Societies (CNS) warmly welcomes the following new members to the IOF family: Read more
El Comité de Asesores Científicos (CSA, por sus siglas en inglés) es la comunidad médica y científica de la International Osteoporosis Foundation (IOF). Está compuesto por 159 expertos globales en el campo de la osteoporosis y la salud musculo esquelética. El Dr. Serge Ferrari es el chair y el Prof. Nicholas Harvey el vice-chair. Los objetivos del CSA son: Read more
The International Osteoporosis Foundation (IOF), the Asian Federation of Osteoporosis Societies (AFOS) and the International Society for Clinical Densitometry (ISCD) have launched a new regional alliance in which the three organizations pledge to collaborate on a common platform to achieve their respective missions. Read more
Formation of the Asia Pacific Fragility Fracture Alliance coincides with an article published in MJA Insight calling for an urgent, cross-disciplinary, multi-sector response to the mounting medical emergency facing Asia’s 4.5 billion inhabitants (comprising 60 per cent of the global population).1 The article appeals for the swift implementation of mobility-maintaining strategies to enable older... Read more
The CCA, composed of leading companies in the musculoskeletal health field, supports IOF and its members’ mission to advance bone health and fracture prevention as a worldwide priority.At its November 8th meeting in Geneva, the CCA members elected Christopher Sherwood (Amgen) as Chair and Lorie Fitzpatrick (Radius) as Vice-Chair of the IOF Committee of Corporate Advisors (CCA). Dr Philippe... Read more


Subscribe to IOF